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Environmental endocrine disruptionEmerging data suggest that environmental endocrine disrupting chemicals may contribute to the patho-
physiology of obesity and diabetes. In a prior work, the phenylsulfamide fungicide tolylﬂuanid (TF)
was shown to augment adipocyte differentiation, yet its effects on mature adipocyte metabolism remain un-
known. Because of the central role of adipose tissue in global energy regulation, the present study tested the
hypothesis that TF modulates insulin action in primary rodent and human adipocytes. Alterations in insulin
signaling in primary mammalian adipocytes were determined by the phosphorylation of Akt, a critical insulin
signaling intermediate. Treatment of primary murine adipose tissue in vitrowith 100 nM TF for 48 h marked-
ly attenuated acute insulin-stimulated Akt phosphorylation in a strain- and species-independent fashion.
Perigonadal, perirenal, and mesenteric fat were all sensitive to TF-induced insulin resistance. A similar TF-
induced reduction in insulin-stimulated Akt phosphorylation was observed in primary human subcutaneous
adipose tissue. TF treatment led to a potent and speciﬁc reduction in insulin receptor substrate-1 (IRS-1)
mRNA and protein levels, a key upstream mediator of insulin's diverse metabolic effects. In contrast, insulin
receptor-β, phosphatidylinositol 3-kinase, and Akt expression were unchanged, indicating a speciﬁc abroga-
tion of insulin signaling. Additionally, TF-treated adipocytes exhibited altered endocrine function with a re-
duction in both basal and insulin-stimulated leptin secretion. These studies demonstrate that TF induces
cellular insulin resistance in primary murine and human adipocytes through a reduction of IRS-1 expression
and protein stability, raising concern about the potential for this fungicide to disrupt metabolism and thereby
contribute to the pathogenesis of diabetes.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Over the last several decades, diabetes rates in the United States
have correlated closely with synthetic organic chemical production
[1]. Given the close connection between obesity and the development
of type 2 diabetes [2], disruption of adipose tissue function may me-
diate global changes in whole-body energy metabolism brought
about by chemical exposure. Several fundamental properties of
body fat make it the perfect metabolic target of endocrine disrupting
chemicals (EDCs).2 Many putative EDCs are highly lipophilic with the0 E. 57th St., Chicago IL 60637,
(M.J. Brady).
id
l rights reserved.capacity to bioaccumulate in the triglyceride stores of the adipocyte
resulting in high local concentrations in fat pads. Thus, even short-
term EDC exposure could lead to long-term effects through slow
leaching of chemicals from lipid droplets. Also, adipocyte differentia-
tion and metabolism are regulated by multiple nuclear hormone re-
ceptors that control gene transcription. Since many of these
transcription factors have lipophilic compounds as their endogenous
ligands, EDCs could interfere with their physiological regulation. In-
deed, EDCs affect estrogen, androgen and thyroid hormone nuclear
receptor activities [3–5], leading some to propose that modulation
of nuclear hormone receptors may result in metabolic disruption [6].
Underscoring the potential role of the adipocyte as an EDC target,
the environmental obesogen hypothesis posits a causal link between
synthetic chemicals and the obesity epidemic [7,8]. Epidemiological
data support a link between particular pollutants and waist-to-hip
ratio as well as body mass index [9]. Furthermore, experimental
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ants to inappropriately modulate adipocyte development [8,10–12].
Less is known, however, about the capacity of EDCs to modulate insu-
lin action and adipocyte metabolism, critical measures of an EDC's po-
tential to contribute to metabolic diseases such as obesity and
diabetes. Population-based studies have correlated exposure to
some environmental contaminants with the development of insulin
resistance or diabetes [13,14]. Most experimental studies have been
restricted to cell lines, which report both an augmentation of
insulin-stimulated metabolism [15] as well as an inhibition of insulin
action [16,17], depending on the EDC studied. More recent evidence,
however, suggests that some pollutants possess the capacity to inhib-
it global insulin action in animal models [18]. However, the molecular
mechanisms responsible for environmental disruption of insulin sig-
naling remain largely undeﬁned.
Adipose tissue performs a central role in energy regulation be-
cause of its ability to store excess calories in times of surfeit while
mobilizing those stores in times of deﬁcit. The balance between stor-
age and mobilization is regulated by several hormones, chief among
these are insulin and catecholamines. Working through its surface re-
ceptor, insulin stimulates a series of intracellular signaling events, in-
cluding the autophosphorylation of the insulin receptor, tyrosine
phosphorylation of insulin receptor substrate-1 (IRS-1), activation
of phosphatidylinositol 3-kinase (PI3K), and elevation of PIP3 levels.
These events lead to the translocation and activation of Akt via phos-
phorylation on serine/threonine residues. Akt plays a critical role in
insulin-stimulated glucose and lipid metabolism in adipose tissue.
The end result of insulin action on the adipocyte is a shift in the met-
abolic balance from energy mobilization to storage and a concomitant
release of the adipokine leptin that regulates feeding behavior. Bio-
chemical insulin resistance can therefore be deﬁned as a relative re-
duction in insulin's ability to trigger its intracellular signaling
cascade. A failure of insulin signaling in adipose tissue prevents the
safe removal and storage of free fatty acids from the circulation,
which subsequently can induce insulin resistance in the liver and
skeletal muscle [19]. Thus, an initiating defect in adipocyte insulin ac-
tion could be the foundational disturbance upon which global energy
regulation is disrupted.
Tolylﬂuanid (TF, Euparen® Multi) is a member of the phenylsulfa-
mide family of fungicides used in antifouling paints as well as on fruit
crops in agricultural areas outside of the United States including Eu-
rope, Australia, and New Zealand [20,21]. TF has the capacity to aug-
ment preadipocyte-to-adipocyte differentiation in the 3T3-L1 cell line
[12] and to bind to the glucocorticoid receptor [22]; however, little is
known about the ability of TF to alter adipocytic insulin signaling and
metabolism. Studies were therefore undertaken to determine wheth-
er this EDC can induce adipocytic insulin resistance and thereby po-
tentially contribute to the metabolic derangements underlying the
development of diabetes.
2. Materials and methods
2.1. Chemicals and reagents
TF was purchased from Fluka (St. Louis, MO). Type II collagenase
(Clostridium histolyticum), puromycin (Streptomyces alboniger), and
all inorganic chemicals were obtained from Sigma (St. Louis, MO).
Fetal bovine serum (FBS) as well as phenol red-free Dulbecco's Mod-
iﬁed Eagle's Medium (DMEM) were obtained from HyClone (Logan,
UT), while DMEM containing phenol red was obtained from Cellgro
(Manassas, VA). Lactate Dehydrogenase (LDH) Cytotoxicity Assay
Kit was obtained from Cayman Chemicals (Ann Arbor, MI). Protein
A Dynabeads were acquired from Invitrogen (Carlsbad, CA). Anti-
phospho-Akt (Ser473), anti-Akt, anti-IRS-1, and anti-PI3K p85 subu-
nit (PI3K-p85) monoclonal antibodies were purchased from Cell
Signaling Technology (Danvers, MA). Anti-insulin receptor-β (IR-β)antibody was purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). Anti-phosphotyrosine antibody was purchased from Millipore
(Billerica, MA). E.N.Z.A. Total RNA Kit II was obtained from Omega
Bio-Tek (Norcross, GA). The iScript cDNA Synthesis Kit was acquired
from Bio-Rad (Hercules, CA). PerfeCTa SYBR Green FastMix was pur-
chased from Quanta BioSciences (Gaithersburg, MD), while the
Mouse Leptin ELISA Kit was obtained from Crystal Chem (Downers
Grove, IL).
2.2. Adipocyte cell culture
Primary adipocytes were obtained from male mice (approximate-
ly 8 weeks of age) and rats (approximately 12 weeks of age) sacri-
ﬁced according to Institutional Animal Care and Use Committee-
approved protocols. Fat pads were harvested by sterile dissection
with careful attention to the removal of the testes and epididymis
from the perigonadal fat. Human adipose tissue from subcutaneous
abdominal fat was obtained from female patients undergoing surgery
for breast reconstruction (n=3) or cosmetic liposuction (n=1) after
obtaining informed consent per an Institutional Review Board-
approved protocol (10-474-A). The dissected fat was placed in
DMEM containing 10% FBS and coarsely minced into chunks weighing
approximately 100–300 mg; these chunks were then equally appor-
tioned into either vehicle- (ethanol) or 100 nM TF-supplemented
DMEM containing 10% FBS and incubated for 48 h at 37 °C in 5%
CO2; the total ethanol concentration was ≤0.1%. Primary adipocytes
were then isolated from fat pads by collagenase digestion and ﬂota-
tion centrifugation as previously described [23].
2.3. Lactate dehydrogenase assay
TF cytotoxicity was assessed using the Lactate Dehydrogenase
(LDH) Cytotoxicity Assay Kit per the manufacturer's instructions
(Cayman). After incubating primary adipocytes for 48 h in the pres-
ence of vehicle or 100 nM TF, aliquots of the culture medium were
taken; total cell LDH content was measured after incubating adipo-
cytes in 0.1% Triton X-100 for 1 h. LDH was reported as percent re-
leased into the medium relative to total cellular LDH content.
2.4. Insulin signaling assays
Isolated adipocytes were equally apportioned into 1.5 ml microfuge
tubes (approximately 100–300 μl of packed cells per tube). Insulin stim-
ulationwas initiated by the addition of an equal volume of Krebs–Ringer
buffer (pH7.4) supplementedwith 1% bovine serumalbumin (BSA), and
3 mMglucose (KRB*)−/+ indicated concentrations of insulin followed
by incubation in a water bath at 37 °C for 10 min with gentle vortexing
every 2 min. Insulin action was terminated by addition of ice-cold KRB*
and placing the cells on ice. The adipocytes were then washed twice
with ice-cold KRB (lacking BSA) to remove the excess BSA. Samples for
immunoblotting were prepared by the addition of an equal volume of
2× HB buffer (prepared from adding equal parts of homogenization
buffer [23] and Laemmli 4× buffer [167 mM Tris, 8 mM EDTA, 27% glyc-
erol, 1.3% β-mercaptoethanol, 416 mM sodium dodecyl sulfate, and
0.3 mM bromophenol blue]) and vigorous vortexing. Samples were
then centrifuged at 9300 ×g at room temperature for 10 min, and the
infranatant layer (between the pelleted cell debris and ﬂoating lipid
layer) was removed and heated at 95 °C for 5 min.
2.5. Immunoprecipitation
Protein lysates from cultured primary adipocytes were prepared
as outlined above except after washing the cultured adipocytes, ho-
mogenization buffer alone was added before centrifuging and remov-
ing the infranatant layer. Immunoprecipitation (IP) of IRS-1 or IR-β
was performed using Protein A Dynabeads per the manufacturer's
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beads for 10 min followed by incubation of the protein lysate with
the bead-antibody complex for an additional 10 min. The supernatant
was removed via magnetic separation and stored for immunoblotting.
The protein–bead complex was then washed multiple times with PBS,
and the isolated proteins were eluted via the addition of Laemmli
Sample Buffer and heating at 95 °C for 5 min. The IP samples under-
went immunoblotting for IRS-1 and the co-IPed protein PI3K-p85,
the regulatory subunit of PI3K. Alternatively, immunoblotting was
performed for IR-β and phospho-tyrosine.
2.6. SDS-PAGE and immunoblotting
All samples were resolved on 10% sodium dodecyl sulfate poly-
acrylamide gels and transferred to polyvinylidene ﬂuoride after pre-
conditioning the membranes in methanol. Western blots were
probed as described [24]. Blots were then incubated with horseradish
peroxidase-conjugated goat anti-rabbit IgG (Bio-Rad) and developed
using Amersham ECL Advance (GE Healthcare). Densitometry was
performed for immunoblots using ImageJ version 1.44 (National In-
stitutes of Health) with the insulin effect determined by calculating
the ratio of the total areas for the bands corresponding to pAkt and
total Akt.
2.7. Quantitative real time PCR (qRT-PCR)
RNA was isolated from cultured primary adipose tissue using the
E.N.Z.A. Total RNA Kit II (Omega). The purity and concentration of
the isolated RNA was assessed using a Nanodrop 2000; 260/280 ratios
were ~2.0. The Bio-Rad iScript Kit was used to synthesize cDNA.
Quantitiative RT-PCR was performed using SYBR green on a Bio-Rad
MyiQ RT-PCR detection system. Primers were from Integrated DNA
Technologies and as follows: 18S rRNA forward 5′-CGGCTACCACATC-
CAAGGA-3′, reverse 5′-GCTGGAATTACCGCGGCT-3′, IRS-1 forward 5′-Fig. 1. Effect of TF on insulin-stimulated Akt phosphorylation in primary rodent adipocyt
100 nM TF for 48 h. Cells were then stimulated for 10 min with the indicated concentration
munoblotting. The phosphorylated-to-total Akt ratio was used to determine insulin action i
where n=4), CD-1 mice (Panel C; n=6 except for 5 nM insulin where n=4), Sprague–D
(Panel E; n=3). Data are presented as means±S.E.M. normalized to vehicle-treated adipo
total cellular LDH as a measure of cytotoxicity. * pb0.05; ** pb0.01; *** pb0.001.GCCAGAGGATCGTCAATAGC-3′, reverse 5′-GAGGAAGACGTGAGGTCC-
TG-3′. Primers were designed using Primer3 and assessed for speciﬁc-
ity by melting curve analysis. Gene expression levels were evaluated
by the delta–delta Ct method after conﬁrmation that ampliﬁcation ef-
ﬁciency was between 90% and 110% for all primer pairs; 18S rRNA
was used as a reference gene to control for total mRNA recovery.
2.8. Protein stability assay
Perigonadal adipose tissue frommale C57BL/6 mice was harvested
and cultured in phenol red-free DMEM with 10% FBS in the presence
of 100 nM TF or vehicle (ethanol). After 12 h, the protein translation
inhibitor puromycin was added to a ﬁnal concentration of 100 μM,
and the fat was incubated for a further 2 h. Cellular levels of IRS-1
were then determined by immunoblotting after IP as described
above.
2.9. Leptin secretion assay
Perigonadal fat pads from male C57BL/6 mice were harvested and
cultured in phenol red-free DMEM with 10% FBS. The tissue samples
were then treated with vehicle or 100 nM TF for 48 h. After 24 h in
culture, insulin was added to a subset of each treatment at a ﬁnal con-
centration of 2.5 nM for the ﬁnal 24 h of TF treatment. Media samples
from the cultured tissues were obtained, and secreted leptin was
measured using the Mouse Leptin ELISA Kit per the manufacturer's
instructions (Crystal Chem).
2.10. Statistical analyses
Signiﬁcance was determined using a two-tailed Student's t-test
for comparisons between two conditions and by analysis of variance
(ANOVA) with Tukey's post-hoc test for comparisons of more than
two conditions using GraphPad Prism version 5.04 (La Jolla, CA).es. Perigonadal depots were sterilely harvested, coarsely minced and incubated with
of insulin. Lysates were prepared and subjected to anti-phospho-Akt and -total Akt im-
n perigonadal fat pads from male C57BL/6 mice (Panel A; n=8 except for 5 nM insulin
awley rats (Panel D; n=6 except for 5 nM insulin where n=5), or Wistar–Kyoto rats
cytes exposed to 10 nM insulin. Panel B shows LDH release into the media relative to
Fig. 2. Depot-speciﬁc sensitivity of adipose tissue to endocrine disruption by TF. Adi-
pose tissue depots were harvested, treated, and analyzed as in Fig. 1. The
phosphorylated-to-total Akt ratio was used to determine insulin action in mesenteric
(Panel A; n=4 except for 5 nM insulin where n=3) and perirenal (Panel B; n=5 ex-
cept for 5 nM insulin where n=4) adipose depots from male CD-1 mice. Data are pre-
sented as means±S.E.M. normalized to vehicle-treated adipocytes exposed to 10 nM
insulin. * pb0.05; ** pb0.01; *** pb0.001.
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3.1. Effect of tolylﬂuanid on insulin signaling in primary rodent
adipocytes
To study the impact of TF pretreatment on insulin signaling in pri-
mary mammalian adipocytes, gonadal fat pads were sterilely re-
moved from C57BL/6 male mice, coarsely minced and incubated for
48 h in media in the absence and presence of 100 nM TF, an60 kD 
0 1 2.5 5 7.5 10 0 1 2.5 5 7.5
Vehicle Tolylfluanid 
Fig. 3. Effect of TF on insulin-stimulated Akt phosphorylation in human adipocytes. Human
curves were performed. A representative immunoblot of insulin-stimulated Akt phosphoryl
insulin action in human fat obtained from surgical patients (n=4 except for 5 nM insulin w
10 nM insulin. *pb0.05.intermediate concentration shown in prior studies to promote adipo-
cyte differentiation in the 3T3-L1 cell line [12]. Tissue pieces were
washed and then stimulated for 10 min with the indicated concentra-
tion of insulin. The relative phosphorylation of Akt under insulin
stimulation was studied by phospho-speciﬁc immunoblotting with
total Akt levels serving as a protein loading control. Exposure of peri-
gonadal fat pads from inbred C57BL/6 mice to 100 nM TF greatly at-
tenuated Akt phosphorylation upon stimulation with 1 and 10 nM
insulin (63% and 30% reduction, respectively) (Fig. 1A). These results
were not a consequence of non-speciﬁc, TF-induced cellular toxicity
as there was no detectable increase in LDH release into the media
during the 48 h treatment (Fig. 1B). Additionally, total Akt levels
were unchanged indicating that impairment of insulin signal trans-
duction rather than a reduction of Akt expression was responsible
for the results obtained. The C57BL/6 mouse strain is known to be
particularly prone to insulin resistance [25], so the ability of TF to
modulate insulin action was also tested in fat obtained from the out-
bred CD-1 mouse strain. Again, pretreatment with 100 nM TF reduced
Akt phosphorylation by 61% at 5 nM insulin and by 54% at 10 nM in-
sulin relative to vehicle-treated controls (Fig. 1C). To ensure that this
was not a species-speciﬁc effect, adipocytes from two strains of rat
were subjected to similar analysis. Exposure of adipocytes to
100 nM TF from Sprague–Dawley rats (Fig. 1D) as well as Wistar–
Kyoto rats (Fig. 1E) inhibited insulin-stimulated Akt phosphorylation.
For Sprague–Dawley rats, TF reduced Akt phosphorylation by 96% and
51% at 1 nM and 10 nM insulin, respectively; in adipocytes fromWis-
tar–Kyoto rats, Akt phosphorylation was reduced by 92% and 36% at
1 nM and 10 nM insulin, respectively.
3.2. Effects of tolylﬂuanid on insulin signaling in speciﬁc fat depots
Adipose tissue from different fat depots varies in its metabolic be-
havior, with visceral fat being particularly deleterious to health [26].
To determine whether fat from various depots differ in their sensitiv-
ity to TF, insulin signaling after TF treatment was analyzed in mesen-
teric and perirenal fat in CD-1 mice since these depots are most
similar to human visceral fat. Under these conditions, TF reduced
insulin-stimulated Akt phosphorylation in adipocytes from the mes-
enteric fat pad by 89% and 50% at 1 nM and 10 nM insulin, respective-
ly (Fig. 2A). Akt phosphorylation in perirenal fat cells was reduced by
81% and 25% at 1 nM and 5 nM insulin, respectively (Fig. 2B).
3.3. Effect of tolylﬂuanid on insulin signaling in primary human
adipocytes
While TF consistently reduced insulin-stimulated Akt phosphory-
lation in rodent adipocytes, the ultimate question related to the po-
tential diabetogenic properties of this chemical pertains to its abilitypAkt 
Total Akt 
Ins (nM) 10
adipose tissue was pretreated for 48 h with 100 nM TF, and then insulin dose–response
ation is shown (Panel A). The phosphorylated-to-total Akt ratio was used to determine
here n=3) (Panel B). Data were normalized to vehicle-treated adipocytes exposed to
IP
: I
R
S-
1
Ce
ll 
Ly
sa
te
Vehicle TF
Fig. 4.Mechanism of TF-induced insulin resistance. Perigonadal fat frommale C57/BL6 mice was treated as in Fig. 1. Levels of IR-β, PI3K, and total Akt were measured in cell lysates,
while IRS-1 and IRS-1-associated PI3K were assessed after immunoprecipitation. Representative immunoblots are shown (Left) as well as cumulative densitometry for each protein
as means±S.E.M. normalized to vehicle-treated controls (n=4–6). IRS-1 densitometry is represented by IRS-1/Akt and IP PI3K-p85 densitometry is represented by IP PI3K-P85/
supernatant PI3K-P85, each independently normalized to vehicle. ***pb0.001.
Fig. 5. Effect of TF on IRS-1 gene transcription. RNA was isolated from cultured C57BL/6
perigonadal fat pads after 48 h incubation with 100 nM tolylﬂuanid and reverse tran-
scribed. Quantitative RT-PCR was used to assess fold change differences between IRS-
1 expression in vehicle- versus TF-treated adipocytes. Data are presented as means±
S.E.M. of the fold induction of IRS-1 relative to 18S rRNA normalized to vehicle-
treated controls (n=6). ***pb0.001.
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bility, human subcutaneous abdominal adipose tissue was obtained
from volunteer female patients undergoing breast reconstruction or
cosmetic liposuction. Data obtained for subcutaneous adipose tissue
from women undergoing the two procedures were similar; therefore,
the data were pooled. Analysis of the combined data revealed that
treatment with TF signiﬁcantly reduced insulin-stimulated Akt phos-
phorylation by 72% and 53% at 1 nM and 2.5 nM insulin, respectively
(Fig. 3). Thus, TF treatment induced insulin resistance in primary ad-
ipose tissue from three mammalian species, including humans.
3.4. Mechanism of tolylﬂuanid-induced insulin resistance
To investigate the molecular mechanisms of TF-induced insulin
resistance, the mediators of insulin signal transduction upstream of
Akt phosphorylation were interrogated in vehicle- and TF-treated
perigonadal adipose tissue from C57BL/6 mice (Fig. 4). Levels of IR-
β and p85 regulatory PI3K subunit were unchanged after TF treat-
ment. Likewise, autophosphorylation of IR-β after insulin stimulation
was unaltered by TF treatment (data not shown). In contrast, IRS-1
levels were reduced compared to vehicle-treated controls by 43%,
and in parallel, IRS-1 tyrosine phosphorylation was comparably re-
duced after TF treatment (data not shown). Additionally, while total
cellular levels of PI3K were unchanged, there was a 53% reduction
in PI3K association with IRS-1, a critical step in the activation of the
lipid kinase. Concordant with these studies in primary murine fat,
preliminary experiments demonstrate similar reductions in IRS-1
levels in human adipose tissue (data not shown).
Cellular levels of IRS-1 are controlled by several mechanisms
[27,28]. Using qRT-PCR, the ability of TF to modulate IRS-1 transcrip-
tion was investigated. Treatment of perigonadal fat from C57BL/6
mice with 100 nM TF for 48 h resulted in a 30% reduction in IRS-1
mRNA levels (Fig. 5). Cumulatively, these results indicate TF speciﬁ-
cally reduced cellular IRS-1 levels, likely through a transcriptional
mechanism, which in turn disrupted propagation of insulin signal
transduction and activation of Akt.
3.5. Time- and concentration-dependence of tolylﬂuanid-mediated IRS-1
downregulation
To ascertain the duration of treatment necessary for TF-
mediated downregulation of IRS-1 transcription, gonadal fat from
C57BL/6 mice was treated with vehicle (ethanol) or 100 nM TF for
12–48 h. Relative IRS-1 transcript levels, matched to vehicle-treated controls exposed for the same duration, were reduced by
30% at 24 h and remained signiﬁcantly depressed at later time
points (Fig. 6, Panel A). The dose–response relationship of TF expo-
sure on IRS-1 transcription was determined by exposing gonadal fat
from C57BL/6 mice to either vehicle or 100 pM to 1 μM TF for 48 h.
Relative IRS-1 transcription was signiﬁcantly reduced from 10 nM
to 1 μM with a peak reduction of 44% at 10 nM (Fig. 6, Panel B).
Collectively, these results suggest that TF has the capacity to impair
insulin signal transduction at lower concentrations and after shorter
durations of exposure than initially investigated.3.6. Effect of tolylﬂuanid on IRS-1 protein stability
To determine whether transcriptional downregulation of IRS-1
was solely responsible for reductions of IRS-1 protein levels, the effect
of TF on protein stability was measured. IRS-1 ubiquitination, an im-
portant regulator of proteasomal degradation of IRS-1, was
unchanged by TF treatment (data not shown), suggesting that this
pathway was not the principal mechanism by which TF induces insu-
lin resistance. However, protein stability is governed by processes be-
yond ubiquitination; therefore, the effects of TF on IRS-1 stability
were directly assessed. Primary adipose tissue from male C57BL/6
mice were treated with either vehicle (ethanol) or 100 nM TF for
IP: IRS-1 
Lysate: Akt 
Puromycin - - + +
Fig. 7. Effect of TF on IRS-1 protein stability. Perigonadal fat pads from C57BL/6 mice
were treated with vehicle or 100 nM TF for 12 h followed by incubation with the pro-
tein translation inhibitor puromycin at a ﬁnal concentration of 100 μM for an additional
2 h. Levels of Akt were measured in cell lysates, while IRS-1 protein levels were deter-
mined after immunoprecipitation. Representative immunoblots (bottom) are shown as
well as cumulative densitometry for IRS-1 as means±S.E.M. normalized to vehicle-
treated controls (n=3). IRS-1 densitometry is expressed as IRS-1/Akt normalized to
vehicle (ethanol). *pb0.05; ***pb0.001.
Fig. 6. Time- and concentration-dependence of TF-mediated IRS-1 downregulation. For
time-dependence (Panel A), RNA was isolated from cultured C57BL/6 perigonadal fat
pads after 12–48 h incubation with 100 nM tolylﬂuanid or vehicle (ethanol, EtOH).
For concentration-dependence (Panel B), RNA was similarly isolated after exposure
to vehicle or TF at concentrations ranging from 100 pM to 1 μM. Isolated RNA was
reverse transcribed, and qRT-PCR was used to assess fold change differences between
vehicle- versus TF-treated adipocytes. Data are presented as means±S.E.M. of the
fold induction of IRS-1 relative to 18S rRNA normalized to vehicle-treated controls
(n=3–5 for time-dependence; n=4 for concentration-dependence). *pb0.05;
**pb0.01; ***pb0.001.
Vehicle 
TF 
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main unchanged. The protein translation inhibitor puromycin was
then added to a ﬁnal concentration of 100 μM for an additional 2 h.
Relative to untreated controls, puromycin treatment resulted in a
33% reduction in IRS-1 levels in vehicle-treated adipocytes (Fig. 7).
After pretreatment with TF, puromycin reduced IRS-1 protein levels
by 64%. Thus, compared to puromycin-treated controls, TF increased
the degradation of IRS-1 protein by 54%. In contrast, Akt levels were
unchanged demonstrating that the puromycin was not exerting a
toxic effect on the cells.Fig. 8. Effect of TF on Leptin Secretion. Perigonadal fat pads from C57BL/6 mice were
treated with TF for 48 h. A subset of samples were also treated for the ﬁnal 24 h of
the 48 h incubation period with 2.5 nM insulin. Aliquots of media were then analyzed
for leptin secretion. Data are presented as means±S.E.M (n=7) normalized to the
vehicle-treated, insulin-stimulated condition. *pb0.05; ***pb0.001.3.7. Effect of tolylfuanid on adipocytic leptin secretion
To investigate the physiological consequences of TF-mediated dis-
ruption of insulin signaling on adipocyte physiology, studies were
performed to interrogate the effects of this novel endocrine disruptor
on leptin production. Treatment of primary adipocytes from C57BL/6
mice with 100 nM TF resulted in a 17% reduction in basal leptin secre-
tion over 48 h (Fig. 8, Panel A). Treatment of adipocytes with 2.5 nM
insulin for 24 h augmented leptin secretion by 74%; however, TF
treatment reduced insulin-stimulated leptin secretion by 15%
(Fig. 8, Panel B). Because of the central role of leptin in regulating
global energy metabolism [29], these results suggest that disruption
of insulin signaling by TF results in a phenotypic change in theadipocyte that could promote alterations in global energy regulation
that favor weight gain.4. Discussion
The phenylsulfamide class of fungicides includes TF and dichlo-
ﬂuanid, a structural analogue of TF that differs solely by the absence
of a phenolic methyl group. Both of these fungicides are used in agri-
culture as well as in the shipping industry as booster biocides in anti-
fouling paints where they are used to limit adherence of organisms to
ships’ hulls. Tissue levels of phenylsulfamides in humans have not
been reported; however, there is ample evidence of human exposure.
Approximately 20% of apples tested in the Czech Republic [30] and
46% analyzed in Slovenia were shown to be TF-positive [31]. In fact,
TF was among the most common pesticides detected in fruits and
vegetables in southeastern Poland at concentrations up to 1.44 mg/
Fig. 9. Overview of effects of TF on the insulin signal transduction cascade in adipose tissue.
Insulin binding to its cell surface receptor (IR) results in auto-transphosphorylation of the
two β-subunits and activation of the insulin receptor's intrinsic tyrosine kinase activity.
This leads to tyrosine phosphorylation of IRS-1, which recruits and activates PI3K through
action on the regulatory subunit (p85) leading to the generation of higher ordered lipids
(PIP3). Generation of PIP3 recruits Akt to the cell membrane where it is activated by
serine/threonine phosphorylation prior to conducting its downstream effects. TF reduces
cellular insulin sensitivity by reducing IRS-1 levels.
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approximately 13 mg/kg four days after the most recent application
[33]. Importantly, washing did not signiﬁcantly reduce TF residues
on apples [30]. Marine concentrations of phenylsulfamides are a con-
sequence of both agricultural run-off as well as leaching from anti-
fouling paints, with levels varying depending upon local agricultural
and shipping activities. Reported dichloﬂuanid concentrations in ma-
rine waters are as high as 1.8 nM (reviewed in Ref. [34]), with worst
case predictions up to 17.4 nM [35]. Importantly, recent bans on
organotin-based antifouling paints are predicted to increase use of al-
ternative booster biocides, including phenylsulfamide fungicides,
with an expected rise in environmental levels [35]. In addition to ex-
posure among the general population, some individuals are at height-
ened risk through occupational exposure to phenylsulfamides,
including farm workers during harvesting activities (average hand
exposure to dichloﬂuanid of 1.14 mg/m2/h with maximum wrist ex-
posure of 4.87 mg/m2/h) [36] and shipyard workers applying marine
paints (potential dermal exposure to dichloﬂuanid of 277 mg/h (for
hands) and 267 mg/h (for total body less hands) [37]. Precise extrap-
olation of these environmental levels and occupational exposures to
in vivo concentrations are difﬁcult in the absence of direct measure-
ments; however, it is expected that bioaccumulation of phenylsulfa-
mides in adipose tissue would be signiﬁcant given their highly
hydrophobic character (e.g. log partition coefﬁcient of octanol-to-
water of 3.9 for TF) [20]. Current evidence suggesting that TF has
the capacity to augment adipocyte differentiation [12] and impair in-
sulin action should prompt efforts to measure phenylsulfamide levels
in exposed populations in order to assess their role in the pathogen-
esis of obesity and diabetes.
Despite evidence for human exposure, the metabolic effects of TF
have not been previously studied. Because of the importance of adi-
pocytes in the control of global energy homeostasis, studies were un-
dertaken to determine the effect of TF on adipocytic insulin signaling.
Under insulin stimulation, a series of intracellular signaling events
takes place including the phosphorylation of Akt, a critical regulator
of glucose and lipid metabolism and gene transcription [38]. Initial
analysis revealed that TF treatment of adipocytes from the perigona-
dal fat pad of two strains of mice (with differing propensities to de-
velop diabetes), as well as two strains of rat, resulted in a dramatic
attenuation of insulin-stimulated Akt phosphorylation. Similar stud-
ies were also performed using human adipose tissue obtained from
surgical patients. Consistent with the effects observed with rodent
adipocytes, TF pretreatment decreased subsequent insulin signaling
in human fat, suggesting that humans may be sensitive to the delete-
rious metabolic effects of this fungicide.
It is now widely recognized that the distribution of adipose tis-
sue has a much greater impact on global insulin sensitivity than the
total amount of body fat. An increase in the waist:hip ratio in
humans, reﬂective of higher amounts of visceral fat, correlates
with a more severe insulin resistance; conversely, accumulation of
adipose mass below the waist in humans (the “pear shape” versus
the “apple shape”) has a much less deleterious effect [26]. To ascer-
tain whether TF reduced insulin sensitivity in the visceral fat com-
partment, mesenteric and perirenal adipose depots were pretreated
with TF to determine their sensitivity to this EDC. Consistent with
data from the perigonadal fat pad, TF inhibited insulin action in
both the mesenteric and perirenal fat pads. Since murine mesenter-
ic and perirenal fat pads are homologous to human visceral fat, the
anti-insulin effect of TF in these depots suggests that the adverse
effects of this metabolic disruptor may compound the additional
mechanisms of insulin resistance inherent to visceral adipose tissue.
Unfortunately, this supposition could not be directly tested using
human visceral fat due to the requirement of surgical intervention
to obtain tissue from this depot.
Although a growing body of epidemiological data has linked EDC
exposure to metabolic derangements in humans, the precisemolecular mechanisms by which these chemicals exert their effects
remain poorly understood. The present study provides evidence
that TF disrupts the insulin-mediated activation of Akt speciﬁcally
through a reduction in IRS-1 levels (Fig. 9). The expression of all
other components of the insulin signaling pathway between the insu-
lin receptor and Akt was unaffected. IRS-1 is a large protein (180 kDa)
that is phosphorylated on tyrosine residues by the insulin receptor,
resulting in the recruitment of various proteins that further transduce
the signal. IRS-1 has many tyrosine as well as serine/threonine resi-
dues that are subject to phosphorylation by a number of kinases
from various signaling cascades. In general, tyrosine phosphorylation
of IRS-1 augments insulin signaling whereas serine/threonine phos-
phorylation diminishes insulin action. Thus, through its phosphoryla-
tion state as well as its overall levels, IRS-1 integrates signals from
multiple signaling cascades to establish the cell's overall responsive-
ness to insulin [28].
The TF-induced reduction of IRS-1 protein levels corresponded
with a decrease in mRNA expression as well as protein stability
for the insulin signaling intermediate. The transcriptional regula-
tion of IRS-1 is complex and not fully deﬁned, and the molecular
intermediaries responsible for the reduction of IRS-1 mRNA levels
in adipose tissue by TF are currently under investigation. IRS-1
protein levels are signaled for degradation at least partially via
ubiquitination [39]; however, TF does not appear to alter this pro-
cess (data not shown). The precise mechanism by which TF desta-
bilizes the IRS-1 protein is actively under study. Interestingly, the
sensitivity of human adipocytes to TF were overcome by high con-
centrations of insulin, whereas rodent adipocytes continued to
show TF-mediated inhibition of insulin-stimulated Akt phosphory-
lation under similar conditions. This apparent discrepancy may re-
ﬂect differences between humans and rodents in the degree to
which they downregulate expression of the insulin receptor in
response to supraphysiologic concentrations of insulin; however,
this may also reﬂect species variability in either the extent or the
mechanism (transcriptional vs. translational) by which TF downre-
gulates IRS-1.
In addition to attenuating the insulin responsiveness of adipo-
cytes, TF alters the endocrine function of fat cells. During TF treat-
ment, leptin secretion into the media is reduced, and while insulin
treatment augments leptin release, treatment with this metabolic dis-
ruptor reduces insulin-stimulated leptin release relative to vehicle-
treated controls. Leptin plays a critical role in global energy balance
with low levels resulting in both a reduction in energy expenditure
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changes promote an increase in the deposition of body fat. Thus, it
is possible that exposure to phenylsulfamide pesticides such as TF
could promote fat accumulation directly through the induction of ad-
ipocyte differentiation [12] as well as indirectly through a modulation
of adipokine production that promotes positive energy balance. Fur-
thermore, adipose tissue accumulation under the inﬂuence of TF
may be particularly deleterious since fat cells exposed to TF are resis-
tant to insulin action, thus favoring a diabetic phenotype.
The described investigations demonstrate a consistent TF-
induced attenuation of insulin action at 100 nM that is strain- and
species-independent. This concentration was selected since it was
an intermediate dose that promoted adipocyte differentiation in
the 3T3-L1 cell line [12], and these studies serve as proof-of-
principle that TF can function as a metabolic disruptor in adipose
tissue. It is important to note the short duration of exposure
(48 h) at which an effect on insulin action was observed in these
studies. Since the relevant human physiological state likely reﬂects
chronic exposure over months or even years, it is possible that
lower doses over a longer period may unmask similar anti-insulin
actions of TF. Furthermore, bioaccumulation of TF is likely given
the chemical's highly hydrophobic character [20]. The capacity of
TF to enrich in the hydrophobic environment of the adipocyte is
particularly important to recognize given that the limited measured
levels of TF in the environment are lower than the treatment doses
used in the present study. Interestingly, the enrichment of EDCs in
fat may partially explain the stronger correlations between POPs
and diabetes among obese individuals in some epidemiological
studies [14]. While this could reﬂect synergistic action between
EDCs and an underlying predisposition to metabolic disruption, it
is possible that bioaccumulation in the adipocyte lipid droplet en-
hances an EDC's capacity to inhibit insulin action, especially given
the critical importance of adipose tissue in regulating global energy
metabolism.
The present study shows that the fungicide and putative endo-
crine disruptor TF impairs adipocytic insulin action, yet, several
open questions remain. While TF consistently decreased insulin ac-
tion in multiple strains of two rodent species, these studies were
restricted to male rodents. Full extrapolation is complicated by
the known inﬂuence of sex steroids on insulin action [40]. Because
similar effects were observed in human adipocytes obtained from
female patients, it is expected that TF would have similar effects
in female rodents; however, the unknown menstrual status of
these patients leaves open the possibility of effect modiﬁcation by
sex steroids. An additional limitation of the current work is the ex
vivo analysis of TF action on insulin signaling. Global energy balance
is a consequence of multiple tissues (e.g. adipose tissue, liver,
muscle, pancreas, and brain) interacting to maintain metabolic
homeostasis. Given the signiﬁcant reductions in adipocytic insulin
action mediated by TF as well as the effects of this chemical on
leptin secretion, carefully controlled in vivo studies examining the
effects of this novel EDC on whole-body energy metabolism are
warranted. Such experiments will also be able to address the
open question of whether metabolism of TF itself inﬂuences its
ability to modulate insulin action. Collectively, these analyses are
critically important for understanding the magnitude of the health
threat posed by this novel metabolic disruptor with the capacity
to adversely affect insulin action in adipose tissue.
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